Architecture and expression of the Nfatc1 gene in lymphocytes

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Rudolf, Ronald ^a   Busch, Rhoda ^a   Patra, Amiya K ^a   Muhammad, Khalid ^a   Avots, Andris ^a   Andrau, Jean Christophe ^b   Klein Hessling, Stefan ^a   Serfling, Edgar ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Chromatin; Induction; Lymphocytes; Nfatc1; Transcription

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD34 ANTIGEN; CYCLOSPORIN A; DEOXYRIBONUCLEASE I; POLYADENYLIC ACID; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CPG ISLAND; DNA METHYLATION; GEL MOBILITY SHIFT ASSAY; GENE; GENE INDUCTION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; INTRON; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; NFATC1 GENE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SHORT SURVEY;

EID: 84895523335     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00021     Document Type: Short Survey

References (31)

1. Bhattacharyya S, Deb J, Patra AK, Thuy Pham DA, Chen W, Vaeth M, et al. NFATc1 affects mouse splenic B cell function by controlling the calcineurin-NFAT signaling network. J Exp Med (2011) 208:823-39. doi: 10.1084/jem.20100945.
2. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature (1998) 392:182-6. doi:10.1038/32419.
3. Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 392:186-90. doi:10.1038/32426.
4. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 4:397-405. doi:10.1016/S1074-7613(00)80253-8.
5. Schuh K, Kneitz B, Heyer J, Bommhardt U, Jankevics E, Berberich-Siebelt F, et al. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 28:2456-66. doi:10.1002/(SICI)1521-4141(199808)28:08<::AID-IMMU2456>3.0.CO;2-9.
6. Xanthoudakis S, Viola JP, Shaw KT, Luo C, Wallace JD, Bozza PT, et al. An enhanced immune response in mice lacking the transcription factor NFAT1. Science (1996) 272:892-5. doi:10.1126/science.272.5263.892.
7. Ranger AM, Oukka M, Rengarajan J, Glimcher LH. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity (1998) 9:627-35. doi:10.1016/S1074-7613(00)80660-3.
8. Samanta DN, Palmetshofer A, Marinkovic D, Wirth T, Serfling E, Nitschke L. B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice. J Immunol (2005) 174:4797-802.
9. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK, et al. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity (2002) 16:881-95. doi:10.1016/S1074-7613(02)00329-1.
10. Serfling E, Avots A, Klein-Hessling S, Rudolf R, Vaeth M, Berberich-Siebelt F. NFATc1/alphaA: the other face of NFAT factors in lymphocytes. Cell Commun Signal (2012) 10:16. doi:10.1186/1478-811X-10-16.
11. Serfling E, Chuvpilo S, Liu J, Hofer T, Palmetshofer A. NFATc1 autoregulation: a crucial step for cell-fate determination. Trends Immunol (2006) 27:461-9. doi:10.1016/j.it.2006.08.005.
12. Akimzhanov A, Krenacs L, Schlegel T, Klein-Hessling S, Bagdi E, Stelkovics E, et al. Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling. Am J Pathol (2008) 172:215-24. doi:10.2353/ajpath.2008.070294.
13. Zhou B, Wu B, Tompkins KL, Boyer KL, Grindley JC, Baldwin HS. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart. Development (2005) 132:1137-46. doi:10.1242/dev.01640.
14. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, et al. The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 28:1045-8. doi:10.1038/nbt1010-1045.
15. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, et al. Active genes are tri-methylated at K4 of histone H3. Nature (2002) 419:407-11. doi:10.1038/nature01080.
16. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 30:155-67. doi:10.1016/j.immuni.2008.12.009.
17. Hock M, Vaeth M, Rudolf R, Patra AK, Pham DA, Muhammad K, et al. NFATc1 induction in peripheral T and B lymphocytes. J Immunol (2013) 190:2345-54. doi:10.4049/jimmunol.1201591.
18. Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol (2011) 18:956-63. doi:10.1038/nsmb.2085.
19. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, et al. Sp1 elements protect a CpG island from de novo methylation. Nature (1994) 371:435-8. doi:10.1038/371435a0.
20. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev (1994) 8:2282-92. doi:10.1101/gad.8.19.2282.
21. Hargreaves DC, Horng T, Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell (2009) 138:129-45. doi:10.1016/j.cell.2009.05.047.
22. Pekowska A, Benoukraf T, Zacarias-Cabeza J, Belhocine M, Koch F, Holota H, et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J (2011) 30:4198-210. doi:10.1038/emboj.2011.295.
23. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A (2010) 107:21931-6. doi:10.1073/pnas.1016071107.
24. Fowler T, Sen R, Roy AL. Regulation of primary response genes. Mol Cell (2011) 44:348-60. doi:10.1016/j.molcel.2011.09.014.
25. Smale ST. Transcriptional regulation in the innate immune system. Curr Opin Immunol (2012) 24:51-7. doi:10.1016/j.coi.2011.12.008.
26. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell (2009) 138:114-28. doi:10.1016/j.cell.2009.04.020.
27. Singh H. Teeing up transcription on CpG islands. Cell (2009) 138:14-6. doi:10.1016/j.cell.2009.06.028.
28. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, et al. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev (2006) 20:282-96. doi:10.1101/gad.1383206.
29. Saunders A, Core LJ, Lis JT. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol (2006) 7:557-67. doi:10.1038/nrm1981.
30. Knoll B, Nordheim A. Functional versatility of transcription factors in the nervous system: the SRF paradigm. Trends Neurosci (2009) 32:432-42. doi:10.1016/j.tins.2009.05.004.
31. Bhatt DM, Pandya-Jones A, Tong A-J, Barozzi I, Lissner M, Natoli G, et al. Transcript dynamics of pro-inflammatory genes uncovered by RNA-Seq analysis of subcellular RNA fractions. Cell (2012) 150:279-90. doi:10.1016/j.cell.2012.05.043.